Introduction: Tobacco warning labels typically feature confronting health risk messages which aim to evoke fear to change behaviour. Evidence shows these graphic health warning labels (GHWLs) can be effective but can also lead to unintended responses, including avoidance or defensiveness. Theory suggests that targeting beliefs about the likelihood and benefits of successfully quitting may increase adaptive responses to risk information.

Methods: Participants with nil imminent quitting intentions were recruited to a randomised controlled trial (RCT) in the UK investigating the effects of receiving daily textual SMS messages targeting risk, self-efficacy, and response-efficacy beliefs on cessation behaviour. To explore their experiences receiving SMS messages during the RCT as well as their naturalistic exposure to GHWLs, we undertook a qualitative investigation conducting semi-structured interviews with 20 participants. Four main themes were generated via thematic analysis.

Results: Participants found efficacy messaging motivating, reporting increased hope for cessation. Further, these messages bolstered knowledge about cessation benefits and treatment options, which may increase treatment-related health literacy. Self-efficacy and response-efficacy messages were well-received and seen to complement each other whereas naturalistic exposure to GHWLs was associated with defensive responses and use of strategies to manage negative affect. GHWLs were seen to contribute to stigmatisation of PWS as part of a broader denormalisation of smoking.

Conclusions: GHWLs in their current form can have unintended consequences for people who smoke and can lead to defensive responses. By contrast, messages that address efficacy beliefs can increase hope, knowledge of cessation supports and motivation, thus supporting adaptive responses to smoking health risks.

Implications: Continued use of confronting GHWLs in their current form should be reconsidered. Future policy and research should investigate how efficacy content can be effectively integrated into tobacco packaging to optimise the impact of this space in targeting determinants of cessation. Efficacy content can give people who smoke hope for the future and valuable information about pathways to cessation. These benefits may have applications in other streams of health promotion such as primary care, m-health initiatives or public service announcements.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ntr/ntae297DOI Listing

Publication Analysis

Top Keywords

efficacy content
12
qualitative investigation
8
warning labels
8
adaptive responses
8
sms messages
8
self-efficacy response-efficacy
8
naturalistic exposure
8
exposure ghwls
8
knowledge cessation
8
cessation benefits
8

Similar Publications

Background: Consistent evidence shows stigma impedes healthcare access in people living with HIV (PLWH) and men who have sex with men (MSM). We evaluated the impact of a stigma reduction training for providers whose design was informed by direct observation of their clinical behaviors obtained through visits by incognito standardized patient (SP).

Setting: We conducted this study in in sexually transmitted infection clinics in Guangzhou, China.

View Article and Find Full Text PDF

The remediation of oil-contaminated soil poses significant environmental challenges, often necessitating innovative approaches for effective and sustainable solutions. This study focuses on the synthesis, characterisation, and application of biodegradable capsules loaded with surfactant for enhanced oil remediation of a clean sand. By controlling the release properties of capsules, the research aims to overcome the limitations of conventional surfactant-based remediation methods, such as rapid washout and reduced efficacy over time.

View Article and Find Full Text PDF

Dynamics and triggers of misinformation on vaccines.

PLoS One

January 2025

Centro Ricerche Enrico Fermi, Rome, Italy.

The Covid-19 pandemic has sparked renewed attention to the risks of online misinformation, emphasizing its impact on individuals' quality of life through the spread of health-related myths and misconceptions. In this study, we analyze 6 years (2016-2021) of Italian vaccine debate across diverse social media platforms (Facebook, Instagram, Twitter, YouTube), encompassing all major news sources-both questionable and reliable. We first use the symbolic transfer entropy analysis of news production time-series to dynamically determine which category of sources, questionable or reliable, causally drives the agenda on vaccines.

View Article and Find Full Text PDF

Impulse control disorders in Parkinson's disease: What's new?

J Neurol

January 2025

Parkinson's Disease Research Clinic, Macquarie University, 75 Talavera Road, Sydney, NSW, 2109, Australia.

Impulse Control Disorders (ICDs) are increasingly recognized as a significant non-motor complication in Parkinson's disease (PD), impacting patients and their caregivers. ICDs in PD are primarily associated with dopaminergic treatments, particularly dopamine agonists, though not all patients develop these disorders, indicating a role for genetic and other clinical factors. Studies over the past few years suggest that the mesocorticolimbic reward system, a core neural substrate for impulsivity, is a key contributor to ICDs in PD.

View Article and Find Full Text PDF

Neurotensin receptor agonist PD149163 modulates LPS-induced enterocyte apoptosis by downregulating TNFR pathway and executioner caspase 3 in endotoxemic mice: insights from in vivo and in silico study.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Department of Zoology, University of Allahabad, Senate House, University Road, Old Katra, Prayagraj, Uttar Pradesh, 211002, India.

This study was designed to evaluate the dose-dependent efficacy of neurotensin receptor-1 (NTSR1) agonist PD149163 in the amelioration of the lipopolysaccharide (LPS)-induced apoptosis in the gastrointestinal tract (GIT) of mice. PD149163 is an analogue of NTS, a GIT tri-decapeptide with anti-inflammatory and anti-oxidative effects. Swiss-albino mice (female/8 weeks/25 ± 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!